Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of TScan Therapeutics (NASDAQ:TCRX) through any online brokerage.
Other companies in TScan Therapeutics’s space includes: InflaRx NV (NASDAQ:IFRX), Kezar Life Sciences Inc (NASDAQ:KZR), Coeptis Therapeutics Holdings Inc (NASDAQ:COEP), Citius Oncology Inc (NASDAQ:CTOR) and OS Therapies Inc (AMEX:OSTX).
TScan Therapeutics has a consensus price target of $8.00.
The stock price for TScan Therapeutics (NASDAQ: TCRX) is $0.9976 last updated April 1, 2026 at 9:29 AM EDT.
There are no upcoming dividends for TScan Therapeutics.
TScan Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for TScan Therapeutics.
TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.